[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

James Rickey Biography and Net Worth

SVP, CFO, Treasurer & Secretary of Alpine Immune Sciences

Paul Rickey is the Sr. VP, CFO, Treasurer & Sec. at Alpine Immune Sciences Inc.

How do I contact James Paul Rickey?: The corporate mailing address for Mr. Rickey and other Alpine Immune Sciences executives is 188 East Blaine Street Suite 200, Seattle WA, 98102. Alpine Immune Sciences can also be reached via phone at (206) 788-4545 and via email at [email protected]. Learn More on James Paul Rickey's contact information.
Has James Paul Rickey been buying or selling shares of Alpine Immune Sciences?: James Paul Rickey has not been actively trading shares of Alpine Immune Sciences during the last quarter. Most recently, James Paul Rickey sold 236 shares of the business's stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $22.00, for a transaction totalling $5,192.00. Learn More on James Paul Rickey's trading history.
Who are Alpine Immune Sciences' active insiders?: Alpine Immune Sciences' insider roster includes Robert Conway (Director), Mitchell Gold (CEO), and James Rickey (SVP, CFO, Treasurer & Secretary). Learn More on Alpine Immune Sciences' active insiders.
Are insiders buying or selling shares of Alpine Immune Sciences?: During the last year, insiders at the biotechnology company sold shares 12 times. They sold a total of 315,201 shares worth more than $6,164,078.30. The most recent insider tranaction occured on April, 25th when Director James N Topper sold 19 shares worth more than $1,226.83. Insiders at Alpine Immune Sciences own 42.3% of the company. Learn More about insider trades at Alpine Immune Sciences.
Information on this page was last updated on 4/25/2024.

James Paul Rickey Insider Trading History at Alpine Immune Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
1/25/2024	Sell	236	$22.00	$5,192.00
12/18/2023	Sell	1,800	$19.00	$34,200.00
12/14/2023	Sell	11,600	$19.00	$220,400.00
12/5/2023	Sell	418	$16.01	$6,692.18
11/30/2023	Sell	700	$16.00	$11,200.00
11/6/2023	Sell	18,003	$16.03	$288,588.09
5/30/2019	Buy	10,000	$4.95	$49,500.00

James Paul Rickey Buying and Selling Activity at Alpine Immune Sciences

Alpine Immune Sciences Company Overview

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company's product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Today's Range

Now: $64.97

$64.97

50 Day Range

MA: $64.81

$64.37

$64.97

2 Week Range

Now: $64.97

$8.33

$65.00

Volume

2 shs

Average Volume

1,917,072 shs

Market Capitalization

$4.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97